In a regulatory filing, aTyr Pharma (ATYR) disclosed that its director Jane Gross bought 3.8K shares of common stock on March 17th in a total transaction size of $15K. Shares are up 4.5% afterhours at $4.19.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATYR:
- aTyr Pharma (ATYR) Stock Soars 24% on Promising Drug Developments
- Buy Rating Affirmed for aTyr Pharma Amid Strategic Trial Adjustments and Financial Stability
- aTyr Pharma’s Earnings Call Highlights Progress and Challenges
- Strategic Adjustments and Promising Developments Lead to Buy Rating for aTyr Pharma
- aTyr Pharma Reports 2024 Results and Strategic Progress
Questions or Comments about the article? Write to editor@tipranks.com